Vericel Corp Financials

VCEL Stock  USD 58.14  0.38  0.66%   
Based on the analysis of Vericel Corp's profitability, liquidity, and operating efficiency, Vericel Corp Ord is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December. At this time, Vericel Corp's Property Plant And Equipment Net is quite stable compared to the past year. Net Debt is expected to rise to about 19.9 M this year, although the value of Accumulated Other Comprehensive Income will most likely fall to (105 K). Key indicators impacting Vericel Corp's financial strength include:
Current ValueLast YearChange From Last Year 10 Year Trend
Current Ratio4.274.4948
Notably Down
Slightly volatile
The essential information of the day-to-day investment outlook for Vericel Corp includes many different criteria found on its balance sheet. An individual investor should monitor Vericel Corp's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Vericel Corp.

Net Income

(3.34 Million)

  
Understanding current and past Vericel Corp Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Vericel Corp's financial statements are interrelated, with each one affecting the others. For example, an increase in Vericel Corp's assets may result in an increase in income on the income statement.

Vericel Corp Stock Summary

Vericel Corp competes with Tff Pharmaceuticals, Eliem Therapeutics, Inhibrx, Enliven Therapeutics, and Molecular Partners. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people.
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS92346J1088
CUSIP92346J108 00253U404 00253U305 00253U107
LocationMassachusetts; U.S.A
Business Address64 Sidney Street,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitevcel.com
Phone617 588 5555
CurrencyUSD - US Dollar

Vericel Corp Key Financial Ratios

Vericel Corp Key Balance Sheet Accounts

201920202021202220232024 (projected)
Total Assets153.2M205.6M243.7M273.0M353.7M371.3M
Other Current Liab41K11.3M14.0M16.2M7.9M8.3M
Net Debt814K19.6M(18.2M)(3.5M)19.0M19.9M
Retained Earnings(378.7M)(375.8M)(383.3M)(400.0M)(403.2M)(383.0M)
Accounts Payable6.3M6.8M9.0M16.9M22.3M23.5M
Cash26.9M33.6M68.3M51.1M69.1M72.5M
Net Receivables32.2M34.5M37.4M46.5M58.4M61.3M
Other Current Assets3.0M3.9M4.2M4.8M24.6M25.9M
Total Liab42.1M71.3M73.2M80.7M127.7M134.1M
Total Current Assets111.7M123.6M158.5M186.9M205.6M215.9M
Common Stock489.7M510.1M553.9M593.2M629.2M660.7M
Inventory6.8M9.4M13.4M16.0M13.1M13.7M
Net Tangible Assets111.1M134.3M170.5M184.8M212.5M223.1M

Vericel Corp Key Cash Accounts

201920202021202220232024 (projected)
Change In Cash8.7M6.9M34.7M(17.5M)35.8M37.6M
Free Cash Flow(9.8M)14.9M21.1M10.1M7.8M8.2M
Depreciation1.7M2.4M3.0M4.0M4.6M4.9M
Other Non Cash Items2.8M4.4M4.4M3.7M(369K)(350.6K)
Capital Expenditures2.6M2.6M7.9M7.6M27.5M28.9M
Net Income(9.7M)2.9M(7.5M)(16.7M)(3.2M)(3.3M)
End Period Cash Flow27.0M33.8M68.5M51.1M86.9M91.2M
Change To Inventory(3.3M)(2.5M)(4.0M)(2.6M)2.9M3.0M
Change Receivables(8.7M)(2.3M)(2.9M)(9.1M)(8.2M)(7.8M)
Change To Netincome13.2M13.9M34.3M37.2M42.8M44.9M
Investments13.2M(14.5M)4.4M(36.2M)(16.8M)(17.6M)

Vericel Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Vericel Corp's current stock value. Our valuation model uses many indicators to compare Vericel Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Vericel Corp competition to find correlations between indicators driving Vericel Corp's intrinsic value. More Info.
Vericel Corp Ord is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . At this time, Vericel Corp's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Vericel Corp by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Vericel Corp Ord Systematic Risk

Vericel Corp's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Vericel Corp volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Vericel Corp Ord correlated with the market. If Beta is less than 0 Vericel Corp generally moves in the opposite direction as compared to the market. If Vericel Corp Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Vericel Corp Ord is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Vericel Corp is generally in the same direction as the market. If Beta > 1 Vericel Corp moves generally in the same direction as, but more than the movement of the benchmark.

Vericel Corp Thematic Clasifications

Vericel Corp Ord is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Pharmaceutical ProductsView
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas
Today, most investors in Vericel Corp Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Vericel Corp's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Vericel Corp growth as a starting point in their analysis.

Price Earnings To Growth Ratio

6.91

At this time, Vericel Corp's Price Earnings To Growth Ratio is quite stable compared to the past year.

Vericel Corp November 30, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Vericel Corp help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Vericel Corp Ord. We use our internally-developed statistical techniques to arrive at the intrinsic value of Vericel Corp Ord based on widely used predictive technical indicators. In general, we focus on analyzing Vericel Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Vericel Corp's daily price indicators and compare them against related drivers.
When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vericel Corp Ord. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.045
Earnings Share
0.08
Revenue Per Share
4.685
Quarterly Revenue Growth
0.27
Return On Assets
(0)
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.